Search

Your search keyword '"Periapical Diseases metabolism"' showing total 45 results

Search Constraints

Start Over You searched for: Descriptor "Periapical Diseases metabolism" Remove constraint Descriptor: "Periapical Diseases metabolism"
45 results on '"Periapical Diseases metabolism"'

Search Results

1. Interleukin 17 expression in periapical lesions from elderly patients.

2. Imipramine treatment reverses depressive- and anxiety-like behaviors, normalize adrenocorticotropic hormone, and reduces interleukin-1β in the brain of rats subjected to experimental periapical lesion.

3. The Expression of Interferon Regulatory Factor 8 in Human Periapical Lesions.

4. Comparative Expression of CD34, Intercellular Adhesion Molecule-1, and Podoplanin and the Presence of Mast Cells in Periapical Granulomas, Cysts, and Residual Cysts.

5. Periapical infection may affect birth outcomes via systemic inflammation.

6. Immunohistochemical Analysis of Galectins-1, -3, and -7 in Periapical Granulomas, Radicular Cysts, and Residual Radicular Cysts.

7. The roles of autophagy and hypoxia in human inflammatory periapical lesions.

8. Modulation of Matrix Metalloproteinase 14, Tissue Inhibitor of Metalloproteinase 3, Tissue Inhibitor of Metalloproteinase 4, and Inducible Nitric Oxide Synthase in the Development of Periapical Lesions.

9. Periapical Lesions Increase Macrophage Infiltration and Inflammatory Signaling in Muscle Tissue of Rats.

10. High-mobility Group Box 1 Is Associated with the Inflammatory Infiltration and Alveolar Bone Destruction in Rats Experimental Periapical Lesions.

11. Transforming growth factor beta-1 expression in macrophages of human chronic periapical diseases.

12. Expression of the stem cell factor in fibroblasts, endothelial cells, and macrophages in periapical tissues in human chronic periapical diseases.

13. Expression of hypoxia-induced semaphorin 7A correlates with the severity of inflammation and osteoclastogenesis in experimentally induced periapical lesions.

14. Biomarkers in the dentin-pulp complex: role in health and disease.

15. Different correlation of sphingosine-1-phosphate receptor 1 with receptor activator of nuclear factor kappa B ligand and regulatory T cells in rat periapical lesions.

16. Bisphosphonate uptake in areas of tooth extraction or periapical disease.

17. Association of matrix metalloproteinase inducer (EMMPRIN) with the expression of matrix metalloproteinases-1, -2 and -9 during periapical lesion development.

18. Vitapex can promote the expression of BMP-2 during the bone regeneration of periapical lesions in rats.

19. Expression of a cytokine, interleukin-23, in experimental periapical lesions.

20. Long-term sequential receptor activator of NF-κB ligand (RANKL) and osteoprotegrin (OPG) expression in lipopolysaccharide-induced rat periapical lesions.

21. Immunohistochemical expression of Notch signaling in the lining epithelium of periapical cysts.

22. Inflammatory cytokines in saliva: early signs of metabolic disorders in chronic kidney disease. A controlled cross-sectional study.

23. Effect of alendronate on alveolar bone resorption and angiogenesis in rats with experimental periapical lesions.

24. CCR2 deficiency results in increased osteolysis in experimental periapical lesions in mice.

25. [Criteries of the regeneration intensity in bone jaw's tissue during treatment of inflammatory destructive processes].

26. Correlation between the expression of c-Fos and osteoclasts in induced periapical lesions in rats.

27. Interferon-gamma, interleukin-10, Intercellular adhesion molecule-1, and chemokine receptor 5, but not interleukin-4, attenuate the development of periapical lesions.

28. The effect of estrogen deficiency on receptor activator of nuclear factor kappa B ligand and osteoprotegerin synthesis in periapical lesions induced in rats.

29. Interleukin-17 plays a role in exacerbation of inflammation within chronic periapical lesions.

30. Quantitative analysis of osteoclast-specific gene markers stimulated by lipopolysaccharide.

32. The role of nitric oxide in oral diseases.

33. Identification of GM3 as a marker of therapy-resistant periradicular lesions.

34. Toll-like receptor 4-deficient mice have reduced bone destruction following mixed anaerobic infection.

35. Immune response in chronic periapical parodonititis.

36. Sex hormone receptor status of the dental pulp and lesions of pulpal origin.

37. Presence of secretory IgA in human periapical lesions.

38. Characterization of bone resorptive mediators in active periapical lesions.

39. [Lymphocyte subpopulations in inflammatory periapical lesions. A histopathological and immunohistochemical study in 10 cases].

40. Inflammatory and immunological aspects of the pathogenesis of human periapical lesions.

41. [Dentistry and the microworld called inflammation].

42. The demonstration of alpha 1 antitrypsin in periapical lesions.

43. Antibiotics in exudate from periapical lesions in dogs.

44. Leukotrienes: inflammatory mediators--a review.

Catalog

Books, media, physical & digital resources